TK & Partners

What TK & Partners does

TK & Partners is a private venture capital firm headquartered at Gaysorn Tower in Bangkok, Thailand, founded in 2021 by Dr. Tomas Koch, a former Senior Partner at McKinsey. The firm invests in early-stage deep tech startups across Southeast Asia and globally, with a stated healthcare focus spanning Screening and Diagnosis, Treatment Planning and Delivery, and Remote Monitoring. Over the past five years, TK & Partners has deployed capital across 34 startups with ticket sizes of $100k-$500k USD per deal, investing from Seed to Pre-Series B stages through both equity and structured debt vehicles.

The firm operates two investment models: Model A provides standard capital plus advisory support, while Model B is a venture builder offering that assembles an integrated founder team alongside seed funding and corporate-partner-enabled scale-up capital. TK & Partners positions itself as an activist investor delivering hands-on operational support across strategy, team building, financial controls, KPI management, fundraising preparation, and market access. The firm manages approximately $30 million in annual investment capital and targets a 10x multiple on invested capital within five years.

TK & Partners maintains a regional footprint across Thailand, Singapore, Vietnam, Myanmar, Cambodia, Laos, and Malaysia, with corporate partnerships including Bangchak Corporation PCL. The firm actively participates in regional industry events such as GITEX DigiHealth and Biotech Thailand 2025 and Techsauce Global Summit 2025, and in April 2026 led an oversubscribed $4.3 million seed financing for Acurion alongside Mesa Verde Venture Partners, the National Foundation for Cancer Research, the Asian Fund for Cancer Research, and Bootstrap Ventures.

Name

TK & Partners

Legal name

TK & Partners Co., Ltd

Website

https://tk-partners.co

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

TK & Partners is a Bangkok-based private venture capital firm founded in 2021 by former McKinsey Senior Partner Tomas Koch, investing $100k-$500k tickets in early-stage deep tech healthcare startups from Seed to Pre-Series B across Southeast Asia.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Venture capital funding
• Early-stage investments
• Healthcare startups
• Seed round investing
• Southeast Asia venture

Headquarters

HQ city

Bangkok

HQ country

Thailand

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns (Carried Interest): Returns from successful portfolio company exits generating MOIC (Multiple on Invested Capital) of 10x within 5 years targeted. Traditional VC economics with carried interest on profits from investments.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

TK & Partners is a private venture capital firm that invests in early-stage deep tech healthcare startups from Seed to Pre-Series B stages, with ticket sizes of $100k–$500k USD per investment. The firm deploys capital via flexible vehicles (equity and structured debt) and provides hands-on operational support spanning strategy, team building, financial and KPI controls, execution assistance, and market access, targeting 10x MOIC within 5 years.

Product overview

TK & Partners is a private venture capital firm offering investment services rather than a software product company. The firm operates two primary investment models: Model A (Standard Investment) providing capital and advisory support, and Model B (Integrated Founder Team) offering a venture builder approach with an integrated founder team. Their core offering is venture capital investment in early-stage deep tech healthcare startups across Seed to Pre-Series B stages, with flexible investment vehicles including equity and structured capital. The firm provides hands-on support through strategy, expertise, capital, people, execution, and market access.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investment Services Early-stage venture capital investment services targeting Seed to Pre-Series B deep tech healthcare startups, with $100k–$500k USD tickets deployed via equity or structured capital (debt) and supported by hands-on strategy, team setup, financial/KPI controls, execution assistance, and market access.
• Model A (Standard Investment) Standard investment model providing capital and advisory support to early-stage startups without forming an integrated founder team; designed for founders who already have a team in place and need funding plus strategic guidance.
• Model B - Integrated Founder Team Venture builder model forging a deeper partnership with startups by forming an integrated founder team of dedicated full-time founders, managers, and team members alongside initial seed funding and access to scale-up funding via corporate partnerships.

Quantifiable outcome

• 10x MOIC within 5 years targeted for investments
• +2 more outcomes

Named customers32 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• Bangchak Corporation PCLminorStrategic or Co-development PartnerTKP hosted Bangchak Corporation PCL, Bangchak Initiative and Innovation Center, and their Management Trainee cohort for an in-depth knowledge-sharing session. Part of TKP's ecosystem building and corporate engagement activities.
• GITEX DigiHealth & Biotech ThailandminorStrategic or Co-development PartnerTKP participated in GITEX DigiHealth & Biotech Thailand 2025, a major healthcare and biotech event in Thailand. TKP focused on healthcare innovation at the event.
• Techsauce Global SummitminorStrategic or Co-development PartnerTKP participated in Techsauce Global Summit 2025 with portfolio company ArcFusion showcasing at the event. Part of TKP's support for portfolio company growth and market access.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• East Ventures: Leading Southeast Asian early-stage VC with deep presence in Indonesia and Singapore. Comparable to TKP as a regional seed-to-Series A investor backing technology-enabled startups across multiple verticals.
• Saison Capital: Singapore-headquartered early-stage VC investing in Southeast Asia and emerging markets. Comparable to TKP in stage focus (seed to pre-Series A), check size range, and operator-style support model.
• Wavemaker Partners: SEA-focused early-stage VC with offices in Singapore, LA, and Bangkok. Comparable to TKP for its dual presence in deep tech and healthcare, and similar pre-Series A / Series A check sizes.
• Antler: Global early-stage VC with strong Southeast Asia presence; backs founders from inception with capital and operating support. Comparable to TKP's Model B integrated founder team approach.
• Openspace Ventures: Singapore-based VC investing across Southeast Asia at Series A and beyond. Comparable to TKP for regional SEA focus and active hands-on support to portfolio companies.
• Monk's Hill Ventures: Singapore-based early-stage VC backing Southeast Asian tech founders from pre-seed to Series A. Comparable to TKP in stage, region, and founder-led, operationally engaged investment style.
• Golden Gate Ventures: Singapore-based early-stage venture capital firm investing across Southeast Asia. Highly comparable to TKP given its regional focus, early-stage check sizes, and founder-led model with operating support.

Broad incumbents

• Vertex Ventures: Larger, established VC network with a dedicated Southeast Asia fund. Comparable to TKP as a regional healthcare and tech investor, but operates at broader scale and later stages.
• 500 Global: Global early-stage VC and accelerator with significant Southeast Asia activity. Comparable to TKP for early-stage check sizes and accelerator-style support, but at much larger scale and AUM.

Regional players

• SEEDS Capital (Enterprise Singapore): Singapore government-linked VC arm co-investing in early-stage deep tech and healthcare startups. Comparable to TKP as a co-investor in regional deep tech healthcare rounds, though government-backed and Singapore-anchored.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tk-and-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TK & Partners